Objective: To evaluate the early results of endoscopic treatment of vesicoureteral reflux (VUR) in children using polyacrylate polyalcohol copolymer (PPC). Patients and Methods: We retrospectively reviewed 45 patients treated with subureteric injection of PPC in our clinic. The results of voiding cystouretrography performed on the 3rd postoperative month and the results of 1-year follow-up were evaluated. Results: A total of 45 patients (57 ureters) underwent injection of PPC. The mean age of the patients was 6.5 years. There were 6 (10.5%) grade 1, 7 (12.2%) grade 2, 26 (45.6%) grade 3, 16 (28%) grade 4, and 2 (3.5%) grade 5 VUR. There were 11 overactive bladders, 2 duplex collecting systems, and 4 posterior urethral valves among the patients. Voiding cystouretrography postoperatively at the 3rd month showed that VUR had disappeared in 82.5% (47/57) of the ureters, downgraded to grade 2 and 3 in 7% (4/57), persisted in 5.2% (3/57) and upgraded in 5.2% (3/57). The success rate at the end of the first year was 98.1%. The procedure was free of complications such as fever, dysuria, lumbar pain or obstruction in all patients. No patient showed VUR recurrence at the end of the first year. Conclusions: The short-term results of our patients suggested that PPC can be safely and successfully used in the endoscopic treatment of VUR in children. However, further prospective, controlled trials showing the long-term results of the patients are needed.

Keywords:
Vesicoureteral reflux, Endoscopic treatment, Polyacrylate polyalcohol copolymer
1.
Savage DC, Wilson MI, McHardy M, et al: Covert bacteriuria of childhood. A clinical and epidemiological study. Arch Dis Child 1973;48:8-20.
2.
Khoury A, Bagli D: Reflux and megaureter; in Wein AJ, Kavoussi LR, Novick AC, et al (eds): Campbell-Walsh Urology, ed 9. Philadelphia, Saunders, 2007, pp 3423-3481.
3.
Matouschek E: Treatment of vesicoureteral reflux by transurethral Teflon-injection. Urologe A 1981;20:263-264.
4.
Guerra LA, Khanna P, Levasseur M, et al: Endoscopic treatment of vesicoureteral reflux with Deflux: a Canadian experience. Can Urol Assoc J 2007;1:41-45.
5.
Malizia AA Jr, Reiman HM, Myers RP, et al: Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA 1984;251:3277-3281.
6.
Haferkamp A, Möhring K, Staehler G, et al: Long-term efficacy of subureteral collagen injection for endoscopic treatment of vesicoureteral reflux in neurogenic bladder cases. J Urol 2000;163:274-277.
7.
Leonard MP, Decter A, Mix LW, et al: Endoscopic treatment of vesicoureteral reflux with collagen: preliminary report and cost analysis. J Urol 1996;155:1716-1720.
8.
Dodat H, Aubert D, Chavrier Y, et al: Vesicoureteral reflux in children: long-term results of endoscopic treatment by Macroplastique injection. Prog Urol 2004;14:380-384.
9.
Aaronson IA, Rames RA, Greene WB, et al: Endoscopic treatment of reflux: migration of Teflon to the lungs, brain. Eur Urol 1993;23:394-399.
10.
Capozza N, Lais A, Nappo S, et al: The role of endoscopic treatment of vesicoureteral reflux: a 17-year experience. J Urol 2004;172:1626-1628.
11.
Ferrer FA, McKenna PH, Hochman HI, et al: Results of a vesicoureteral reflux practice pattern survey among American Academy of Pediatrics, Section on Pediatric Urology members. J Urol 1998;160:1031-1037.
12.
Report of the International Reflux Study Committee: Medical versus surgical treatment of primary vesicoureteral reflux - a prospective international reflux study in children. J Urol 1981;125:277-283.
13.
O'Donnell B, Puri P: Treatment of vesicoureteric reflux by endoscopic injection of Teflon. Br Med J 1984;289:7-9.
14.
Ormaechea M, Paladini M, Pisano R, et al: Vantris, a biocompatible, synthetic, non-biodegradable, easy-to-inject bulking substance. Evaluation of local tissular reaction, localized migration and long-distance migration. Arch Esp Urol 2008;61:263-268.
15.
Elder JS, Peters CA, Arant BS Jr, et al: Pediatric vesicoureteral reflux guidelines panel summary report on the management of primary vesicoureteral reflux in children. J Urol 1997;157:1846-1851.
16.
Elder JS, Diaz M, Caldamone AA, et al: Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. J Urol 2006;175:716-722.
17.
Ormaechea M, Ruiz E, Denes E, et al: New tissue bulking agent (polyacrylate polyalchol) for treating vesicoureteral reflux: preliminary results in children. J Urol 2010;183:714-718.
18.
Chertin B, Arafeh WA, Zeldin A, et al: Preliminary data on endoscopic treatment of vesicoureteral reflux with polyacrylate polyalchol copolymer (Vantris®): surgical outcome following single injection. J Pediatr Urol 2011;7:654-657.
19.
Alizadeh F, Mazdak H, Khorrami MH, et al: Postoperative ureteral obstruction after endoscopic treatment of vesicoureteral reflux with polyacrylate polyalchol copolymer (Vantris®). J Pediatr Urol 2013;9:488-492.
20.
McLaren CJ, Simpson ET: Direct comparison of radiology and nuclear medicine cystograms in young infants with vesico-ureteral reflux. BJU Int 2001;87:93-97.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.